These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 34199418)
1. Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor. Lee J; Avramets D; Jeon B; Choo H Molecules; 2021 Jun; 26(11):. PubMed ID: 34199418 [TBL] [Abstract][Full Text] [Related]
2. Structure-Activity Relationships and Therapeutic Potentials of 5-HT Modica MN; Lacivita E; Intagliata S; Salerno L; Romeo G; Pittalà V; Leopoldo M J Med Chem; 2018 Oct; 61(19):8475-8503. PubMed ID: 29767995 [TBL] [Abstract][Full Text] [Related]
3. Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons. Speranza L; Labus J; Volpicelli F; Guseva D; Lacivita E; Leopoldo M; Bellenchi GC; di Porzio U; Bijata M; Perrone-Capano C; Ponimaskin E J Neurochem; 2017 Jun; 141(5):647-661. PubMed ID: 28122114 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome. De Filippis B; Nativio P; Fabbri A; Ricceri L; Adriani W; Lacivita E; Leopoldo M; Passarelli F; Fuso A; Laviola G Neuropsychopharmacology; 2014 Oct; 39(11):2506-18. PubMed ID: 24809912 [TBL] [Abstract][Full Text] [Related]
5. Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder. Lacivita E; Niso M; Mastromarino M; Garcia Silva A; Resch C; Zeug A; Loza MI; Castro M; Ponimaskin E; Leopoldo M ACS Chem Neurosci; 2021 Apr; 12(8):1313-1327. PubMed ID: 33792287 [TBL] [Abstract][Full Text] [Related]
6. Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment. Lee A; Choo H; Jeon B Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742963 [TBL] [Abstract][Full Text] [Related]
7. Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome. Valenti D; de Bari L; Vigli D; Lacivita E; Leopoldo M; Laviola G; Vacca RA; De Filippis B Neuropharmacology; 2017 Jul; 121():79-88. PubMed ID: 28419872 [TBL] [Abstract][Full Text] [Related]
8. Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date. Nikiforuk A CNS Drugs; 2015 Apr; 29(4):265-75. PubMed ID: 25721336 [TBL] [Abstract][Full Text] [Related]
9. Chemical update on the potential for serotonin 5-HT Kucwaj-Brysz K; Baltrukevich H; Czarnota K; Handzlik J Bioorg Med Chem Lett; 2021 Oct; 49():128275. PubMed ID: 34311086 [TBL] [Abstract][Full Text] [Related]
10. Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders. Crider A; Pillai A J Pharmacol Exp Ther; 2017 Jan; 360(1):48-58. PubMed ID: 27789681 [TBL] [Abstract][Full Text] [Related]
11. An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse Models. Canal CE; Felsing DE; Liu Y; Zhu W; Wood JT; Perry CK; Vemula R; Booth RG ACS Chem Neurosci; 2015 Jul; 6(7):1259-70. PubMed ID: 26011730 [TBL] [Abstract][Full Text] [Related]
12. Targeting 5-HT receptors for the treatment of obesity. Sargent BJ; Henderson AJ Curr Opin Pharmacol; 2011 Feb; 11(1):52-8. PubMed ID: 21330209 [TBL] [Abstract][Full Text] [Related]
13. The role of serotonin receptors in the action of atypical antipsychotic drugs. Meltzer HY; Massey BW Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology and Therapeutic Potential of the 5-HT Blattner KM; Canney DJ; Pippin DA; Blass BE ACS Chem Neurosci; 2019 Jan; 10(1):89-119. PubMed ID: 30020772 [TBL] [Abstract][Full Text] [Related]
15. Effects of 5-HT-7 receptor ligands on memory and cognition. Zareifopoulos N; Papatheodoropoulos C Neurobiol Learn Mem; 2016 Dec; 136():204-209. PubMed ID: 27780766 [TBL] [Abstract][Full Text] [Related]
16. Cholesterol alterations in fragile X syndrome, autism spectrum disorders and other neurodevelopmental disorders. Benachenhou S; Laroui A; Dionne O; Rojas D; Toupin A; Çaku A Int Rev Neurobiol; 2023; 173():115-139. PubMed ID: 37993175 [TBL] [Abstract][Full Text] [Related]
17. Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists. Pranzatelli MR Arch Neurol; 1994 Jun; 51(6):605-17. PubMed ID: 7515228 [TBL] [Abstract][Full Text] [Related]
18. Aminotriazines with indole motif as novel, 5-HT Kułaga D; Jaśkowska J; Satała G; Latacz G; Śliwa P Bioorg Chem; 2020 Nov; 104():104254. PubMed ID: 32919133 [TBL] [Abstract][Full Text] [Related]
19. 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. Kvachnina E; Liu G; Dityatev A; Renner U; Dumuis A; Richter DW; Dityateva G; Schachner M; Voyno-Yasenetskaya TA; Ponimaskin EG J Neurosci; 2005 Aug; 25(34):7821-30. PubMed ID: 16120784 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Membranes of Human SH-SY5Y Neuroblastoma Cells Express Serotonin 5-HT Tempio A; Niso M; Laera L; Trisolini L; Favia M; Ciranna L; Marzulli D; Petrosillo G; Pierri CL; Lacivita E; Leopoldo M Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]